NEUBASE THERAPEUTICS INC (64132K201) Stock Institutional Trading Activity


NEUBASE THERAPEUTICS INC (64132K201) position changes reported by tracked institutional filers across multiple SEC 13F reporting periods. Based on recent SEC 13F filings (Q1 2024), investors with some of the largest reported share count changes include Renaissance Technologies LLC and Greenlight Capital. Explore insights into buying and selling patterns, position changes, and investment conviction levels to understand institutional trading behavior and market dynamics.

Explore more:

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q1 2024Renaissance Technologies LLCBuy31,26288,229$40
Q4 2023Renaissance Technologies LLCBuy44,36656,967$42
Q2 2023Renaissance Technologies LLCBuy12,60112,601$24
Q2 2023Greenlight CapitalBuy136,350136,350$254,975

Frequently asked questions about 64132K201 activity

  • Which institutional owners are buying 64132K201?

    Institutional owners buying 64132K201 include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in 64132K201 activity?

    "Buy" means an investor increased their reported position in 64132K201 compared to the prior reporting period. This reflects growing exposure to NEUBASE THERAPEUTICS INC (64132K201) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in 64132K201 increasing?

    Institutional interest in 64132K201 can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.